MADISON, Wis., Jan. 8, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, ...
Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of ...
Madison-based Elephas Biosciences Corp. announced Monday the completion of a $41.5 million Series B funding round. The round was led by Chicago-based ARCH Venture Partners with continued investment by ...
Investment company Elephas Investment Management Ltd (Current Portfolio) buys Baidu Inc, sells Tesla Inc, JinkoSolar Holding Co, Daqo New Energy Corp during the 3-months ended 2021Q1, according to the ...
Arch Venture Partners leads round to advance company's novel live tumor diagnostic platform MADISON, Wis., Sept. 6, 2022 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Madison-based cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results